Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
05:02:03 EDT Sun 13 Sep 2026
Enter Symbol
or Name
USA
CA



Forgot password?
Trouble logging in?
Login ID:
Password:
Save

T:MSCL - SATELLOS BIOSCIENCE INC. - https://satellos.com/
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
MSCL - T  0.513.10·14.200.313.20-0.73-5.28.81178413.99  14.16  13.2018.98  7.3215:58:51Sep 0915 min RT 2¢
TSX - T0.513.10·14.200.313.20-0.73-5.27.1945813.99  14.16  13.2018.98  7.3215:58:5115 min
NEO ATS - U 13.930.0021    Sep 1015 min
CSE ATS - P 13.20-0.73-5.20.68714.02  14.02  13.2015:56:0415 min
CXC - X 13.930.0022    Sep 1015 min
CXD - D 13.70-0.23-1.70.22413.70  13.70  13.7009:51:1315 min
MatchNOW - M 13.930.81111    15 min
Lynx - Y 14.14+0.211.50.11114.14  14.14  14.1410:55:1915 min

Recent Trades - Last 10 of 84
Time ETExPriceChangeVolumeBuyerSellerMarkers
16:11:12X13.20-0.73180 National Bank80 National BankZW
16:11:12X13.20-0.73180 National Bank80 National BankZW
15:58:51T13.20-0.73200124 Questrade79 CIBCK
15:58:51T13.20-0.73100124 Questrade1 AnonymousK
15:58:51T13.20-0.73100124 Questrade79 CIBCK
15:58:41T13.20-0.73200124 Questrade53 Morgan StanleyK
15:58:40T13.20-0.73100124 Questrade79 CIBCK
15:58:37T13.20-0.73100124 Questrade1 AnonymousK
15:58:23T13.20-0.73100124 Questrade79 CIBCK
15:58:17T13.20-0.73100124 Questrade1 AnonymousK

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolPriceTypeHeadline
2026-09-09 12:10C:MSCL12.77News ReleaseSatellos receives name "forazapadin" for SAT-3247
2026-09-01 07:00C:MSCL13.01News ReleaseSatellos to Participate in Upcoming Investor Conferences
2026-08-13 17:02C:MSCL13.85News ReleaseSatellos Reports Second Quarter 2026 Financial Results and Highlights Company Progress
2026-08-13 11:22C:MSCL13.85SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2026-08-13 11:22C:MSCL13.85SEDAR Interim MD & ASEDAR Interim MD & A
2026-07-08 12:53C:MSCL11.55News ReleaseSatellos releases six-month DMD interim trial data
2026-06-29 15:43C:MSCL10.20News ReleaseSatellos receives fast-track designation for SAT-3247
2026-06-25 07:00C:MSCL7.93News ReleaseSatellos to Present Clinical Program Updates at ICNMD 2026
2026-06-17 21:14C:MSCL8.12News ReleaseSatellos Bioscience holders approve AGM resolutions
2026-05-27 07:00C:MSCL9.35News ReleaseSatellos to Participate in Upcoming Investor Conferences
2026-05-15 18:48C:MSCL9.95News ReleaseSatellos's March 31 cash at $69.9-million
2026-05-15 17:31C:MSCL9.95SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2026-05-15 17:31C:MSCL9.95SEDAR Interim MD & ASEDAR Interim MD & A
2026-04-09 07:00C:MSCL8.65News ReleaseSatellos to Present at the Bloom Burton & Co. Healthcare Investor Conference
2026-03-27 07:00C:MSCL9.60News ReleaseSatellos Reports 2025 Financial Results and Highlights Recent Company Progress
2026-03-10 07:00C:MSCL15.77News ReleaseSatellos Presents Interim SAT-3247 Clinical and Biomarker Data in Duchenne Muscular Dystrophy at the 2026 MDA Clinical & Scientific Conference
2026-02-24 07:00C:MSCL15.36News ReleaseSatellos Announces Upcoming Oral and Poster Presentations at the 2026 Muscular Dystrophy Association Clinical & Scientific Conference
2026-02-18 07:00C:MSCL15.58News ReleaseSatellos to Host Virtual KOL Event on SAT-3247 in Duchenne Muscular Dystrophy
2026-02-17 07:00C:MSCL15.74News ReleaseSatellos to Participate in Upcoming Investor Conferences
2026-02-12 12:38C:MSCL15.77News ReleaseSatellos says first participant dosed in DMD study